1. Home
  2. HUMA vs SCHL Comparison

HUMA vs SCHL Comparison

Compare HUMA & SCHL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • HUMA
  • SCHL
  • Stock Information
  • Founded
  • HUMA 2004
  • SCHL 1920
  • Country
  • HUMA United States
  • SCHL United States
  • Employees
  • HUMA N/A
  • SCHL N/A
  • Industry
  • HUMA Biotechnology: Pharmaceutical Preparations
  • SCHL Books
  • Sector
  • HUMA Health Care
  • SCHL Consumer Discretionary
  • Exchange
  • HUMA Nasdaq
  • SCHL Nasdaq
  • Market Cap
  • HUMA 221.8M
  • SCHL 501.9M
  • IPO Year
  • HUMA N/A
  • SCHL 1987
  • Fundamental
  • Price
  • HUMA $1.21
  • SCHL $18.97
  • Analyst Decision
  • HUMA Strong Buy
  • SCHL
  • Analyst Count
  • HUMA 6
  • SCHL 0
  • Target Price
  • HUMA $14.60
  • SCHL N/A
  • AVG Volume (30 Days)
  • HUMA 2.9M
  • SCHL 338.1K
  • Earning Date
  • HUMA 05-20-2025
  • SCHL 03-20-2025
  • Dividend Yield
  • HUMA N/A
  • SCHL 4.20%
  • EPS Growth
  • HUMA N/A
  • SCHL N/A
  • EPS
  • HUMA N/A
  • SCHL 0.65
  • Revenue
  • HUMA N/A
  • SCHL $1,592,100,000.00
  • Revenue This Year
  • HUMA N/A
  • SCHL $3.42
  • Revenue Next Year
  • HUMA $1,178.20
  • SCHL $5.47
  • P/E Ratio
  • HUMA N/A
  • SCHL $29.19
  • Revenue Growth
  • HUMA N/A
  • SCHL N/A
  • 52 Week Low
  • HUMA $1.15
  • SCHL $15.77
  • 52 Week High
  • HUMA $9.97
  • SCHL $38.77
  • Technical
  • Relative Strength Index (RSI)
  • HUMA 30.35
  • SCHL 57.78
  • Support Level
  • HUMA $1.35
  • SCHL $18.13
  • Resistance Level
  • HUMA $1.48
  • SCHL $19.13
  • Average True Range (ATR)
  • HUMA 0.10
  • SCHL 0.65
  • MACD
  • HUMA 0.03
  • SCHL 0.28
  • Stochastic Oscillator
  • HUMA 4.26
  • SCHL 88.55

About HUMA Humacyte Inc.

Humacyte Inc is developing a disruptive biotechnology platform to deliver universally implantable bioengineered human tissues and organs designed to improve the lives of patients and transform the practice of medicine. It develops and manufactures acellular tissues to treat a wide range of diseases, injuries, and chronic conditions. Company's pipeline includes Vascular Trauma, PAD, Dailysis, Acellular Tissue Engineered Vessels, Advanced Organ Systems, Advanced Tissue Constructs.

About SCHL Scholastic Corporation

Scholastic Corp is an American publishing and education media company that focuses on books and educational material for schools, teachers, parents, and children. It creates print, digital, and audiobooks, learning materials and programs, classroom magazines, and other products that support children's learning and reading both at home and at school. The company also owns rights to various books, including Harry Potter, Dog Man, and The Hunger Games among others. It has three reportable segments Children's Book Publishing and Distribution, Education Solutions, and International. The majority of its revenue is from the Children's Book Publishing and Distribution segment.

Share on Social Networks: